REN and pulmonary arterial hypertension: Both rat BM MSC-EVs and human BM MSC-EVs demonstrated therapeutic effects on PAH disease models (Chen et al., 2014; Liu et al., 2018; Hogan et al., 2019), and involved mechanisms included regulating renin-angiotensin system and improving mitochondrial function.